The FDA recently approved which of the following treatments for pediatric patients with advanced stage CD20+ DLBCL, Burkitt lymphoma, Burkitt-like lymphoma, or mature B-cell acute leukemia.
The FDA recently approved which of the following treatments for pediatric patients with advanced stage CD20+ DLBCL, Burkitt lymphoma, Burkitt-like lymphoma, or mature B-cell acute leukemia.
The FDA recently approved which...